Life Sciences Patent Network Europe 2024 Conference

Ballard Spahr Intellectual Property Partner Dr. Kenneth H. Sonnenfeld, Ph.D., will speak at the Life Science Patent Network's Europe 2024 Conference on December 3 in London. With fellow panelists Damaso Gallardo, Hillary van der Hoff, and Fiona Bor, Dr. Sonnenfeld will present on "Aligning Innovation, Regulation, and Intellectual Property Protection" from 10:10 a.m. until 11:10 a.m. GMT.

The event description:

Navigating the intricate interplay between innovation, regulatory compliance, and intellectual property protection poses unique challenges for the life sciences sector across Europe. This panel discussion will delve into the critical intersections and best practices for aligning groundbreaking research with evolving regulatory frameworks while safeguarding valuable intellectual assets.

• Critical timelines and touch points where innovation, regulation, and IP intersect
• Relationship between regulatory data protection and patent exclusivities
• Implications of the EU Bolar exemption and its impact on generics/biosimilars
• Complexities of the EU Orphan Drug Regulation and its interplay with patent rights
• Strategies for seamless cross-functional collaboration and risk mitigation

Panelists

• Damaso Gallardo, IP Expert, European Patent Attorney Farmaprojects
• Hillary van der Hoff, Vice President, Intellectual Property, T-Therapeutics
• Fiona Bor, Vice President, Head of Intellectual Property, Bicycle Therapeutics
• Kenneth Sonnenfeld, Ph.D., Partner, Ballard Spahr